Fibrinogen from Bovine Plasma Lyophilized

CAT:
952-P2010009
Size:
100 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Fibrinogen from Bovine Plasma Lyophilized - image 1

Fibrinogen from Bovine Plasma Lyophilized

  • Description:

    Fibrinogen from Bovine Plasma_x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_
    Catalog number:P2010009
    Lot number:Batch Dependent
    Expiration date:Batch Dependent
    Package Size:100 mg
    Synonym:Factor I
    Molecular Weight:340 kDa
    Appearance:Lyophilized powder
    Storage:-20°C or lower. Avoid repeated freeze-thaw.
    purity:>95%
    Source:Bovine plasma
    Recommended buffer:0.9% NaCl at 37 °C.
    _x000D_  _x000D_ _x000D_ References_x000D_
      _x000D_
    • Whyte CS, Morrow GB, Mitchell JL, Chowdary P, Mutch NJ. Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19. J Thromb Haemost. 2020 Apr 23.
    • _x000D_
    • Santos AS, Oliveira AJF, Barbosa MCL, Nogueira JLDS. Viscoelastic haemostatic assays in the perioperative period of surgical procedures: Systematic review and meta-analysis. J Clin Anesth. 2020 Apr 13;64:109809.
    • _x000D_
    • Rehiman SH, Lim SM, Neoh CF, Majeed ABA, Chin AV, Tan MP, Kamaruzzaman SB, Ramasamy K. Proteomics as a reliable approach for discovery of blood-based Alzheimer’s disease biomarkers: a systematic review and meta-analysis. Ageing Res Rev. 2020 Apr 12:101066.
    • _x000D_
    • Solaimanzadeh I. Acetazolamide, Nifedipine and Phosphodiesterase Inhibitors: Rationale for Their Utilization as Adjunctive Countermeasures in the Treatment of Coronavirus Disease 2019 (COVID-19). Cureus. 2020 Mar 20;12(3):e7343.
    • _x000D_
    • Valade S, Mariotte E, Azoulay E. Coagulation Disorders in Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome. Crit Care Clin. 2020 Apr;36(2):415-426.
    • _x000D_
    • Ciftciler R, Ciftciler AE, Malkan UY, Haznedaroglu IC. Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper). SAGE Open Med. 2020 Feb 16;8:2050312120907811.
    • _x000D_
    • Zhou J, Lu Y, Wang S, Chen K. Association between serum amyloid A levels and coronary heart disease: a systematic review and meta-analysis of 26 studies. Inflamm Res. 2020 Apr;69(4):331-345.
    • _x000D_
    • Steinbicker AU, Wittenmeier E, Goobie SM. Pediatric non-red cell blood product transfusion practices: what’s the evidence to guide transfusion of the ‘yellow’ blood products? Curr Opin Anaesthesiol. 2020 Apr;33(2):259-267.
    • _x000D_
    • Zaidi A, Kohli R, Daru J, Estcourt L, Khan KS, Thangaratinam S, Green L. Early Use of Fibrinogen Replacement Therapy in Postpartum Hemorrhage-A Systematic Review. Transfus Med Rev. 2020 Jan 28. pii: S0887-7963(20)30009-2.
    • _x000D_
  • Short Description:

    Catalog #: P2010009 - 100 mg
  • Weight:

    0.15
  • Length:

    2
  • Width:

    0.5
  • Height:

    0.5
  • Height :

    0.5